dan forche, ceo of preludedx: molecular diagnostics and precision medicine for breast cancer
Published 11 months ago • 149 plays • Length 6:40Download video MP4
Download video MP3
Similar videos
-
17:01
breast cancer genomics and precision cancer medicine | dana-farber cancer institute
-
1:00:08
precision medicine in oncology
-
9:03
molecular subtype of pdac
-
17:30
precision medicine in the treatment of breast cancer of relating treatments to mutation
-
6:47
molecular re-classification of breast cancer – part 1: rebecca dent
-
58:15
science says: the promise of precision oncology
-
12:31
precision diagnostics for blood cancers and solid tumours - professor anna schuh
-
57:44
medicine for members: precision breast cancer medicine
-
33:23
oncotype dx breast recurrence score assay after tailorx and rxponder: what’s next?
-
1:19:09
systems and solutions for your contact lenses with dr. susan gromacki od, ms
-
28:31
virtual pink house: tamoxifen & aromatase inhibitors in er breast cancer
-
1:06
do you need genetic testing for breast cancer?
-
4:12
cdk4/6, et, lhrh combo improves pfs in premenopausal breast cancer
-
53:25
cso forum -- the future of precision medicine
-
3:11
precision medicine and liquid biopsy: the future of diagnosing and managing disease
-
1:29
dr. charles m. perou on the evolution of precision medicine in breast cancer
-
1:59
how is precision medicine used in the treatment of lung cancer? | dana-farber cancer institute
-
2:54
what is precision cancer medicine? | dana-farber cancer institute
-
0:45
do clinical and pathological factors preduct extended endocrine benefit
-
1:07:21
ccf webinar: how "liquid biopsies" are helping with precision medicine for patients with cancer
-
0:57
dcis treatment options
-
1:17
dr. overmoyer on inflammatory triple-negative breast cancer